MD Anderson Cancer Center · 3 weeks ago
Postdoctoral Fellow - Cancer Biology
MD Anderson Cancer Center is seeking a full-time postdoctoral fellow in the Department of Cancer Biology to join Dr. Kathleen McAndrews' laboratory. The role focuses on understanding how genetic and therapeutic stresses affect tissue repair and cancer progression, requiring hands-on experience with cell culture and molecular biology techniques.
Health CareHealth DiagnosticsHospitalMedical
Responsibilities
Perform mouse genetics experiments coupled with in vitro and in vivo mechanistic studies
Document and present findings
Write manuscripts and fellowship applications
Qualification
Required
PhD or MD/PhD in biomedical sciences field
The appointee recently (within three years) completed their education (doctorate) or completed previous postdoctoral experience or graduate medical education
The appointment is temporary
The appointment involves substantial full-time research or scholarship
The appointment is viewed as preparatory for a full-time academic and/or research career
The appointment is not part of a clinical training program
The appointee works under the supervision of a senior scholar or a department in a university or similar research institution (e.g., national laboratory, National Institutes of Health (NIH), etc.)
The appointee has the freedom to and is expected to publish the results of his or her research or scholarship during the period of the appointment
hands-on experience with cell culture
molecular biology techniques
mouse experiments, including proficient mouse handling
a strong interest in understanding tissue microenvironment biology
the desire to tackle a major problem of great significance
Preferred
Bioinformatics experience is a plus
Benefits
Medical
Dental
Paid time off
Retirement
Tuition benefits
Educational opportunities
Individual and team recognition
Company
MD Anderson Cancer Center
MD Anderson Cancer Center is a cancer treatment and research institution which gives treatment, and research of all types of cancer.
Funding
Current Stage
Late StageTotal Funding
$16.2MKey Investors
Break Through CancerGastro-Intestinal Research Foundation
2023-05-16Grant· $2.7M
2023-01-24Grant· $3.5M
2022-04-19Grant· $10M
Recent News
Medical Xpress - latest medical and health news stories
2026-01-08
2026-01-08
Company data provided by crunchbase